Background. Individuals infected with human immunodeficiency virus (HIV) appear to age faster than the general population, possibly related to HIV infection, antiretroviral therapy, and/or social/environmental factors. We evaluated leukocyte telomere length (LTL), a marker of cellular aging, in HIV-infected and uninfected adults.
telomerase activity contributes to maintenance of telomere length in germ cells, embryonic stem cells, tissue-specific adult stem cells, placenta, and activated immune cells [5] . Telomere length is therefore considered to be a marker of cellular replicative history and/or remaining replication capability, and having short telomeres has been linked to many age-associated diseases [6] . HIV infection can lead to chronic immune activation, inflammation, and oxidative stress [7] . In addition, HIV proteins can downmodulate expression of telomerase activity [8, 9] . HIV cART may also contribute to premature telomere shortening [10] through inhibition of the reverse transcriptase activity of human telomerase by nucleoside reverse transcriptase inhibitors (NRTIs) [11] [12] [13] , or induction of oxidative stress by several antiretroviral agents [14, 15] . All of these factors may affect telomeres and cellular aging, and short telomeres have been reported in small studies (n ≤ 30 per group) on lymphocyte subsets from HIV-infected individuals compared with those from uninfected persons [16] [17] [18] . Recently, one larger South African cohort study reported shorter LTL in HIV-infected individuals compared with noninfected controls, suggestive of accelerated biological aging in the HIV population [19] . Taken together, the combination of HIV infection and cART could contribute to premature aging in persons living with HIV through decreased telomerase activity and/or accelerated telomere shortening. We sought to investigate LTL in this population and the factors associated with shorter LTL.
METHODS

Study Design and Population
Study participants were HIV-infected and -uninfected adults (>19 years) enrolled in the prospective Children and women: AntiRetrovirals and the Mechanism of Aging (CARMA) cohort in Vancouver, Canada, between December 2008 and July 2011. All participants provided written informed consent. The study was approved by the University of British Columbia Clinical Research Ethics Board (H08-02018 and H09-02867). Blood samples, as well as relevant demographic, clinical, and behavioral data were collected. Whole-blood relative LTL was measured by quantitative polymerase chain reaction as previously described [20] . Hepatitis C virus (HCV) RNA and high sensitivity C-reactive protein (CRP) testing was done on plasma collected on the day of the visit. More details appear in the Supplementary Data.
Statistical Analyses
The χ 2 test, Student t test, and Wilcoxon rank-sum test were used to compare the demographic and clinical characteristics of study participants at baseline. Univariate linear regression models were used to explore the following explanatory variables in relation to LTL: age, sex, HIV status (infected vs uninfected), HCV infection status (active vs cleared vs never), household income (<$15 000/year vs ≥$15 000/year), race (black, Aboriginal, South Asian vs white), smoking status (current vs previous vs never), smoking exposure ( pack-years), alcohol use (drinkyears), illicit drug use ever (yes vs no), body mass index, and CRP (>3 µg/mL vs 1-3 µg/mL vs <1 µg/mL), controlling for age as appropriate. Variables shown to be important in univariate analysis (P < .15) were used as candidates in the development of a multivariate model. Collinearity between these candidates was determined by examination of contingency tables (Supplementary Table 8 ), and multivariate models were then run, including the strongly collinear variables in turn. Variables that were found to be highly nonsignificant in all models were eliminated going forward. Combinations of remaining variables were then tested, with variables retained in the model as long as the multivariate P value was < .1. Interactions between variables of interest were examined and were included in the models as needed. Finally, effect-size estimate (β) confidence intervals for statistically nonsignificant variables were examined in an effort to determine whether we may have missed potentially important explanatory variables. Because paternal and maternal ages at birth were not initially collected and were unavailable for 43% of the participants, they were omitted during model development. Hepatitis B virus (HBV) infection was omitted because it was rare in our study population. In a secondary analysis to examine the effect of HIV-related variables, we repeated this analysis twice, first including all HIV-infected participants, and then the more homogeneous subgroup of those on cART with undetectable HIV plasma viral load (pVL). HIV-related explanatory variables examined included time since HIV diagnosis, current and nadir CD4 count, current and peak HIV pVL (highest HIV pVL ever recorded dichotomized at 100 000 copies/mL), current cART status, lifetime duration of cART, type of cART at visit, number of cART regimens and NRTIs, number of cART interruptions >1 week, and percentage of time on cART since HIV diagnosis.
To further support our findings, we conducted a sensitivity analysis including only participants for whom biological father's age at birth was available. We built 2 multivariate models: one following the same "rules" as for the all-participants model with respect to variable inclusion, and a second with paternal age also included as a candidate variable. The descriptive statistics and other sensitivity analysis results are presented in the Supplementary Data. Statistical analyses were performed using SAS software version 9.3 (SAS Institute).
RESULTS
Characteristics of the Study Participants
The median age of participants was 40 years (range, 20-76 years) and 38 years (range, 20-73 years) in the HIV-infected and HIV-uninfected groups, respectively. The majority (76%) 
Ex-alcohol user (n = 389) 107 (27) 47 (28) 60 (26) .76 32 (25) 23 (26) were women. There was no significant difference between the 2 groups with respect to age, sex, income, education, or plasma CRP level, and both groups showed similar rates of current smoking and illicit drug use. However, there was a lower proportion of black participants in the HIV-uninfected group and a higher proportion reporting alcohol consumption, and HIV-infected participants had younger parents ( Table 1) . The median lifetime cART duration was 4 years (range, 0-20 years), 8% were cART-naive, and 39% had received ≥4 different cART regimens (Table 2 ).
Univariate Regression Analyses in All Participants
Younger age, black or South Asian race (vs white), older parental ages at birth, and having never been infected with HIV, HBV, or HCV were significantly associated with longer LTL among all participants ( Figure 1 , Supplementary Table 1) . Although no association with sex was seen overall, among white participants, women had longer LTL than men (β = .26, P = .02). Low income, smoking (both current status and pack-years), illicit drug use ever, and alcohol drink-years were all associated with shorter LTL, whereas higher CRP level was not.
Interactions and Collinearity Between Variables
Repeating the univariate analyses in each group ( Figure 1 , Supplementary Table 1 ) revealed a number of potential interactions: smoking status, illicit drug use, and income <$15 000/ year were associated with shorter LTL in HIV-uninfected individuals but not in persons living with HIV. Similarly, HIV infection and income <$15 000/year were only associated with shorter LTL in those who never smoked (data not shown). Finally, HIV infection status was associated with shorter LTL for younger subjects only. Because smoking, race, income, illicit drug use, and HCV infection showed significant collinearity (see contingency tables in Supplementary Table 8) , these variables were considered iteratively for the multivariate model.
HIV-Specific Explanatory Variables
In univariate analysis, having a peak HIV pVL ≥100 000 copies/ mL was the only significant HIV-specific LTL predictor, and this remained true after adjusting for age ( Figure 2 , Supplementary Table 2 ). Neither the time since HIV diagnosis, current HIV pVL, current CD4 count, CD4 nadir, nor length or type of cART exposure showed any association with LTL, before or after adjusting for age or HIV duration, as appropriate. The same was true among the subgroup of HIV-infected participants on cART with an undetectable HIV pVL (n = 126), except that the paternal age association was lost.
Predictors of Shorter LTL
The final multivariate model (R 2 = 0.25) showed that older age, smoking status, HIV infection, and active HCV infection were all independently significantly associated with shorter LTL (39) 55 (44) 27 (31) CRP 1-3 µg/mL 128 (32) 48 (29) 80 (35) 36 (29) 39 (44) CRP >3 µg/mL 99 (25) 43 (26) 56 (24) 32 (25) 21 ( Characteristics were compared between groups using χ 2 , t, or Wilcoxon rank-sum test, as appropriate. c Samples below the lower limit of the assay (0.6 µg/mL, n = 135) were assigned the value of 0.5 µg/mL and those above the higher limit of the assay (40 µg/mL, n = 3) were assigned the value of 40.1 µg/mL. A total of 12 participants (4 HIV-infected and 8 HIV-uninfected) had CRP levels >20 µg/mL, indicative of possible acute infection. . β values and 95% confidence intervals are shown for possible predictors sorted according to their association with LTL: associations with shorter LTL show negative β values. Variables in italics have been adjusted for age at visit as appropriate. Analyses were separated by group: all subjects (light gray triangle), human immunodeficiency virus (HIV)-uninfected subjects (dark gray circle), and HIV-infected subjects (black square). All variables with P < .15 were considered in the multivariate modeling. Abbreviations: BMI, body mass index; CI, confidence interval; CRP, C-reactive protein; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus.
( Table 3) , even after taking into account the interaction between HIV and smoking described above. The magnitude of the effect size estimate (β) suggested that the largest effect on LTL was in association with current smoking. HIV infection and active HCV infection effect-size estimates were comparable to 24 years (95% confidence interval [CI], 13-35 years) and 9 years (1-17 years) of aging, respectively, although the former may be partly confounded by an age × HIV status interaction. Among all HIV-infected participants, older age and active HCV infection were significantly associated with shorter LTL, the latter's effect estimate comparable to over a decade of aging. An alternate model substituting a categorical variable indicating peak HIV pVL ≥100 000 copies/mL in place of HCV status appeared to predict LTL equally well (Table 3) . Among HIV-uninfected participants, only age and smoking were independently associated with shorter LTL (Table 3) . Examining β confidence intervals for statistically nonsignificant variables indicated a possible role for having a detectable HIV pVL at visit, but our sample did not enable us to draw firm conclusions with respect to this variable (see Supplementary Data and Supplementary Tables).
We performed a secondary analysis on a more homogeneous subgroup consisting of HIV-infected individuals on cART having an undetectable HIV pVL at the time of visit (Tables 1 and  2 ). The results were similar to those for all HIV-infected individuals (Table 3, Supplementary Tables 1 and 2 ), except that active HCV was no longer associated with LTL. Finally, a sensitivity analysis among subjects with paternal age at birth data showed similar results as the final multivariate model (Supplementary Tables 3-7 ). Other variables that were considered during modeling include race, HBV infection ever, body mass index, income, pack-years, drink-years, and illicit drug use. These models did not include paternal or maternal age. 
DISCUSSION
In this cohort of 395 HIV-infected and -uninfected adults, after accounting for other important variables, we found that HIV infection and smoking (current more than previous) were strongly associated with shorter LTL. Our data further suggested that HCV infection also negatively affects LTL, particularly in HIV-infected individuals in whom peak HIV viremia also predicts shorter LTL. The effect size estimate (β) on LTL for HIV infection is similar to that seen over a decade of aging, or with current smoking. There was a lack of association between LTL and most HIVspecific factors except peak HIV viremia. Neither time since HIV diagnosis or progression of HIV disease as measured by current or nadir CD4 count were related to LTL. Furthermore, despite in vitro and ex vivo data showing telomerase inhibition by NRTI [11] [12] [13] 21] , we saw no evidence of a relationship between LTL and cART exposure, including cART duration, percentage of time on cART since HIV diagnosis, current treatment status, current type of cART, or number of cART interruptions. These results suggest that chronic inflammation (as reflected by CRP), and/or telomerase inhibition by cART, do not adequately explain the association seen between HIV and shorter LTL. The fact that few study participants (22/163) were currently treated with the NRTIs showing highest telomerase inhibition in vitro (ie, stavudine, zidovudine, or didanosine [12] ) may explain the lack of association between cART and LTL. Taken together, our observations would suggest instead that acquiring the HIV infection itself may exert a negative effect on LTL that neither significantly worsens nor improves with time or with cART but rather is modulated by HIV products or by the immune response toward HIV that takes place early on following infection.
The mechanism behind shorter LTL in HIV-infected individuals remains unknown. A plausible explanation consistent with our findings could involve an early and at least partially irreversible loss of telomere in hematopoietic stem cells, the precursors of leukocytes, especially around the time of primary infection and establishment of HIV, possibly affecting the length of all blood cells' telomeres thereafter. HIV infection and HIV Tat have indeed been shown to down-modulate telomerase expression and activity in various blood cell subtypes [9, 22, 23] .
Incidentally, shorter LTL, a predictor of cardiovascular disease, particularly in younger individuals [24] [25] [26] , could contribute to the reported association between HIV and increased cardiovascular risk [27, 28] . Endothelial progenitor cells are involved in neovascularization and vascular tissue injury repair. Because these and leukocytes are both derived from hematopoietic stem cells, shorter LTL has been proposed to also reflect endothelial cell telomere length [29] . Furthermore, replenishment of leukocytes migrating during inflammation may also trigger increased replication of hematopoietic stem cells and shorten their telomeres (reviewed in [29] ). Although we found no association between current CRP level and LTL at time of visit, it is possible that HIV-induced inflammation and endothelial activation [30] , particularly at times of high viremia, could affect hematopoietic stem cells' telomere length, further reducing LTL and endothelial progenitor cell function. Future studies in various blood cell subsets will be required to explore this hypothesis.
Alternatively, our data are also consistent with the possibility that individuals with short LTL are at higher risk of acquiring HIV. An intriguing preliminary study in healthy individuals showed increased resistance to experimentally induced infection by the common cold virus in participants with longer LTL [31] . Either suggested mechanism would also be consistent with reports of premature cardiovascular aging [28, 32] in this population, irrespective of current HIV viremia, CD4 count or exposure to cART, and independent of traditional cardiovascular risk factors.
Although other mechanisms, such as inhibition of telomerase activity by NRTIs as well as HIV or cART-induced oxidative stress and inflammation, may contribute to telomere shortening in persons living with HIV, our data suggest that these are less important than HIV infection per se, given that HIV disease, cART-related variables, and CRP showed no association with LTL. Nevertheless, the low R 2 of the multivariate model for the HIV-infected group suggests that important but as yet unidentified factors are at play in this population. HCV infection was also associated with shorter LTL in this cohort, in agreement with other studies [33, 34] . This relationship may be linked to decreased lymphocyte telomerase expression or activity [34] and/or to chronic immune activation and inflammation that are reported to be increased in individuals with chronic HCV. Although we likely lacked power to distinguish between active and cleared HCV, our univariate results suggested a stronger effect in individuals with circulating HCV RNA. Given this, it would be of interest to investigate whether HCV therapy and HCV clearance would positively affect LTL.
Our findings are in agreement with previous reports of shorter age-adjusted LTL in current smokers compared with nonsmokers [35] . Indeed, smoking is a well-established risk factor in many disease states, including cardiovascular disease, and is especially prevalent in the HIV population [36] . Although some studies have observed an association between pack-years and LTL, ours did not.
Both smoking and HIV infection elicit similar pathophysiological changes known to be linked with cardiovascular disease, including systemic oxidative stress, endothelial cell dysfunction, and reduced repair capacity of endothelial progenitor cells.
Taken together, although our results highlight the importance of smoking cessation interventions, other factors, identified or not, appear to be more strongly related to LTL shortening in HIV-infected individuals.
In general agreement with existing telomere literature, younger paternal age at birth, higher body mass index, alcohol use, illicit drug use, and low income were all associated in univariate analysis with shorter LTL within the whole cohort. Of these, only paternal age emerged in the multivariate sensitivity analysis. Overall, sex was not associated with LTL, in apparent contrast to other studies reporting longer LTL in women compared with men [37] . The high prevalence of substance use and HCV infection in our cohort may confound sex-related effects on LTL; however, it is noteworthy that previous cohort studies included primarily white individuals. Indeed, we also observed longer LTL in women when restricting our analysis to white participants. The univariate association observed between LTL and low income is consistent with reports of a positive relationship between LTL and socioeconomic measures [38] . In our cohort, low income was correlated with lower education, substance use (smoking, alcohol, illicit drugs), and Aboriginal ethnicity, and likely behaved as a surrogate variable for a number of other factors reportedly linked to LTL, including poor lifestyle habits, poor nutrition, and lower healthcare access.
A strength of this study is the fact that the HIV-infected and uninfected participants shared very similar sociodemographic characteristics, reducing the confounding effect of factors that differ between the HIV population and the general population. A further strength was its larger size compared with other studies of telomeres in HIV. Limitations include the incomplete data on parental ages, and the fact that a small number of HIVuninfected participants may be unaware of their HCV infection. The best measure available to assess the effect of HIV duration was the HIV diagnosis date, but although it was highly correlated with HIV acquisition date (Supplementary Figure 1) , it is not equivalent to date of infection. A number of explanatory variables showed markedly different associations with LTL according to HIV status or other variables and were therefore modified by them. Although we accounted for important interactions, it is possible that unidentified interactions exist.
Cytomegalovirus (CMV) infection has been associated with shorter LTL and immunosenescence [39, 40] , but CMV serology data were not available for this study. Although our 2 groups are expected to have similarly high CMV infection rates, HIV-infected individuals may have higher CMV reactivation rates, possibly confounding our results. Cardiovascular risk could not be estimated due to the unavailability of complete lipid data and family history. Additionally, a number of factors such as exercise, psychological stress, life trauma, mental health, and marital status that have been linked to LTL were not evaluated in our study participants.
In conclusion, after controlling for important variables, we found that HIV infection was independently associated with shorter LTL but cART was not. The HIV effect on LTL, which is consistent with the accelerated biological aging seen in HIV-infected individuals, was modified by smoking. Our results further suggest that the HIV effect is related to immune control of HIV viremia. Finally, HCV infection is also associated with shorter LTL in HIV-infected individuals, whereas in uninfected individuals, smoking is more important.
Further research is needed to determine the clinical significance of shorter LTL and potential usefulness of measuring LTL in HIV-infected individuals as a marker of disease risk, particularly cardiovascular risk [3] . Investigating whether cART and HCV therapy early in infection would influence LTL dynamics, cardiovascular health, and mortality is also needed.
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